Estrogen-induced immune changes within the normal mammary gland

Abstract Breast cancer (BCa) incidence increases following aberrant hormone exposure, which has been linked to direct effects on estrogen receptor (ER)+ mammary epithelium. While estrogen exposure during mammary involution has been shown to drive tumour growth via neutrophils, the potential for the...

Full description

Bibliographic Details
Main Authors: Helen Tower, Genevieve Dall, Ashleigh Davey, Melanie Stewart, Patrick Lanteri, Meagan Ruppert, Maria Lambouras, Ibraheem Nasir, Serene Yeow, Phillip K. Darcy, Wendy V. Ingman, Belinda Parker, Nicole M. Haynes, Kara L. Britt
Format: Article
Language:English
Published: Nature Portfolio 2022-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-21871-4
_version_ 1817970213443862528
author Helen Tower
Genevieve Dall
Ashleigh Davey
Melanie Stewart
Patrick Lanteri
Meagan Ruppert
Maria Lambouras
Ibraheem Nasir
Serene Yeow
Phillip K. Darcy
Wendy V. Ingman
Belinda Parker
Nicole M. Haynes
Kara L. Britt
author_facet Helen Tower
Genevieve Dall
Ashleigh Davey
Melanie Stewart
Patrick Lanteri
Meagan Ruppert
Maria Lambouras
Ibraheem Nasir
Serene Yeow
Phillip K. Darcy
Wendy V. Ingman
Belinda Parker
Nicole M. Haynes
Kara L. Britt
author_sort Helen Tower
collection DOAJ
description Abstract Breast cancer (BCa) incidence increases following aberrant hormone exposure, which has been linked to direct effects on estrogen receptor (ER)+ mammary epithelium. While estrogen exposure during mammary involution has been shown to drive tumour growth via neutrophils, the potential for the ER + immune microenvironment to mediate part (in addition to mammary epithelial cells) of hormonally controlled BCa risk during normal development has not been assessed. We collected mammary tissue, lymph nodes and blood from tumour naïve mice treated with, oophorectomy, estrogen (17β estradiol) or Fulvestrant. Flow cytometry was used to examine the impact on the frequency of innate and adaptive immune cells. Oophorectomy and fulvestrant decreased the proportion of macrophages, particularly pro-tumour polarized M2 macrophages and neutrophils. Conversely, dendritic cells were increased by these therapies, as were eosinophils. Estrogen increased the proportion of M2 macrophages and to a lesser extent CD4-CD8- double negative and FoxP3+ regulatory T cells but decreased CD8 + T cells and B cells. Excluding eosinophils, these changes were restricted to the mammary tissue. This suggests that inhibiting estrogen action lowers the immune suppressive myeloid cells, increases in antigen presentation and eosinophil-mediated direct or indirect cytotoxic effects. In contrast, estrogen exposure, which drives BCa risk, increases the suppressive myeloid cells and reduces anti-tumour cytotoxic T cells. The impact of hormonal exposure on BCa risk, may in part be linked to its immune modulatory activity.
first_indexed 2024-04-13T20:32:14Z
format Article
id doaj.art-49ec8610163947a8b32e9c455e48f421
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-13T20:32:14Z
publishDate 2022-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-49ec8610163947a8b32e9c455e48f4212022-12-22T02:31:09ZengNature PortfolioScientific Reports2045-23222022-11-0112111410.1038/s41598-022-21871-4Estrogen-induced immune changes within the normal mammary glandHelen Tower0Genevieve Dall1Ashleigh Davey2Melanie Stewart3Patrick Lanteri4Meagan Ruppert5Maria Lambouras6Ibraheem Nasir7Serene Yeow8Phillip K. Darcy9Wendy V. Ingman10Belinda Parker11Nicole M. Haynes12Kara L. Britt13Breast Cancer Risk and Prevention Laboratory, Peter MacCallum Cancer CentreBreast Cancer Risk and Prevention Laboratory, Peter MacCallum Cancer CentreBreast Cancer Risk and Prevention Laboratory, Peter MacCallum Cancer CentreBreast Cancer Risk and Prevention Laboratory, Peter MacCallum Cancer CentreBreast Cancer Risk and Prevention Laboratory, Peter MacCallum Cancer CentreBreast Cancer Risk and Prevention Laboratory, Peter MacCallum Cancer CentreBreast Cancer Risk and Prevention Laboratory, Peter MacCallum Cancer CentreBreast Cancer Risk and Prevention Laboratory, Peter MacCallum Cancer CentreBreast Cancer Risk and Prevention Laboratory, Peter MacCallum Cancer CentreSir Peter MacCallum Department of Oncology, The University of MelbourneDiscipline of Surgical Specialties, Adelaide Medical School, The Queen Elizabeth Hospital, University of AdelaideSir Peter MacCallum Department of Oncology, The University of MelbourneSir Peter MacCallum Department of Oncology, The University of MelbourneBreast Cancer Risk and Prevention Laboratory, Peter MacCallum Cancer CentreAbstract Breast cancer (BCa) incidence increases following aberrant hormone exposure, which has been linked to direct effects on estrogen receptor (ER)+ mammary epithelium. While estrogen exposure during mammary involution has been shown to drive tumour growth via neutrophils, the potential for the ER + immune microenvironment to mediate part (in addition to mammary epithelial cells) of hormonally controlled BCa risk during normal development has not been assessed. We collected mammary tissue, lymph nodes and blood from tumour naïve mice treated with, oophorectomy, estrogen (17β estradiol) or Fulvestrant. Flow cytometry was used to examine the impact on the frequency of innate and adaptive immune cells. Oophorectomy and fulvestrant decreased the proportion of macrophages, particularly pro-tumour polarized M2 macrophages and neutrophils. Conversely, dendritic cells were increased by these therapies, as were eosinophils. Estrogen increased the proportion of M2 macrophages and to a lesser extent CD4-CD8- double negative and FoxP3+ regulatory T cells but decreased CD8 + T cells and B cells. Excluding eosinophils, these changes were restricted to the mammary tissue. This suggests that inhibiting estrogen action lowers the immune suppressive myeloid cells, increases in antigen presentation and eosinophil-mediated direct or indirect cytotoxic effects. In contrast, estrogen exposure, which drives BCa risk, increases the suppressive myeloid cells and reduces anti-tumour cytotoxic T cells. The impact of hormonal exposure on BCa risk, may in part be linked to its immune modulatory activity.https://doi.org/10.1038/s41598-022-21871-4
spellingShingle Helen Tower
Genevieve Dall
Ashleigh Davey
Melanie Stewart
Patrick Lanteri
Meagan Ruppert
Maria Lambouras
Ibraheem Nasir
Serene Yeow
Phillip K. Darcy
Wendy V. Ingman
Belinda Parker
Nicole M. Haynes
Kara L. Britt
Estrogen-induced immune changes within the normal mammary gland
Scientific Reports
title Estrogen-induced immune changes within the normal mammary gland
title_full Estrogen-induced immune changes within the normal mammary gland
title_fullStr Estrogen-induced immune changes within the normal mammary gland
title_full_unstemmed Estrogen-induced immune changes within the normal mammary gland
title_short Estrogen-induced immune changes within the normal mammary gland
title_sort estrogen induced immune changes within the normal mammary gland
url https://doi.org/10.1038/s41598-022-21871-4
work_keys_str_mv AT helentower estrogeninducedimmunechangeswithinthenormalmammarygland
AT genevievedall estrogeninducedimmunechangeswithinthenormalmammarygland
AT ashleighdavey estrogeninducedimmunechangeswithinthenormalmammarygland
AT melaniestewart estrogeninducedimmunechangeswithinthenormalmammarygland
AT patricklanteri estrogeninducedimmunechangeswithinthenormalmammarygland
AT meaganruppert estrogeninducedimmunechangeswithinthenormalmammarygland
AT marialambouras estrogeninducedimmunechangeswithinthenormalmammarygland
AT ibraheemnasir estrogeninducedimmunechangeswithinthenormalmammarygland
AT sereneyeow estrogeninducedimmunechangeswithinthenormalmammarygland
AT phillipkdarcy estrogeninducedimmunechangeswithinthenormalmammarygland
AT wendyvingman estrogeninducedimmunechangeswithinthenormalmammarygland
AT belindaparker estrogeninducedimmunechangeswithinthenormalmammarygland
AT nicolemhaynes estrogeninducedimmunechangeswithinthenormalmammarygland
AT karalbritt estrogeninducedimmunechangeswithinthenormalmammarygland